Works by Kato, Terufumi

Results: 81
    1

    Asian Thoracic Oncology Research Group (ATORG) Expert Consensus Statement on MET Alterations in NSCLC: Diagnostic and Therapeutic Considerations.

    Published in:
    Clinical Lung Cancer, 2022, v. 23, n. 8, p. 670, doi. 10.1016/j.cllc.2022.07.012
    By:
    • Myung-Ju Ahn;
    • Mendoza, Marvin Jonne L.;
    • Pavlakis, Nick;
    • Terufumi Kato;
    • Soo, Ross A.;
    • Dong-Wan Kim;
    • Chong Kin Liam;
    • Te-Chun Hsia;
    • Chee Khoon Lee;
    • Thanyanan Reungwetwattana;
    • Sarayut Geater;
    • Siu Hong Chan, Oscar;
    • Naiyarat Prasongsook;
    • Solomon, Benjamin J.;
    • Thi Thai Hoa Nguyen;
    • Toshiyuki Kozuki;
    • Chih-Hsin Yang, James;
    • Yi-Long Wu;
    • Shu Kam Mok, Tony;
    • Shao-Weng Tan, Daniel
    Publication type:
    Article
    2

    Nab-Paclitaxel for Previously Treated Advanced Non-Small Cell Lung C ancer: Analysis of Safety and Efficacy for Patients With Renal Impairment.

    Published in:
    Clinical Lung Cancer, 2022, v. 23, n. 7, p. 585, doi. 10.1016/j.cllc.2022.08.011
    By:
    • Yasuto Yoneshima;
    • Satoshi Morita;
    • Masahiko Ando;
    • Atsushi Nakamura;
    • Shunichiro Iwasawa;
    • Hiroshige Yoshioka;
    • Yasuhiro Goto;
    • Masafumi Takeshita;
    • Toshiyuki Harada;
    • Katsuya Hirano;
    • Tetsuya Oguri;
    • Masashi Kondo;
    • Satoru Miura;
    • Yukio Hosomi;
    • Terufumi Kato;
    • Toshio Kubo;
    • Junji Kishimoto;
    • Nobuyuki Yamamoto;
    • Yoichi Nakanishi;
    • Isamu Okamoto
    Publication type:
    Article
    3

    Veliparib Plus Carboplatin and Paclitaxel Versus Investigator's Choice of Standard Chemotherapy in Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer.

    Published in:
    Clinical Lung Cancer, 2022, v. 23, n. 3, p. 214, doi. 10.1016/j.cllc.2022.01.005
    By:
    • Govindan, Ramaswamy;
    • Lind, Mike;
    • Insa, Amelia;
    • Khan, Saad A.;
    • Uskov, Dmitry;
    • Tafreshi, Ali;
    • Guclu, Salih;
    • Bar, Jair;
    • Terufumi Kato;
    • Ki Hyeong Lee;
    • Kazuhiko Nakagawa;
    • Hansen, Olfred;
    • Biesma, Bonne;
    • Kundu, Madan G.;
    • Dunbar, Martin;
    • Lei He;
    • Ansell, Peter;
    • Sehgal, Vasudha;
    • Xin Huang;
    • Glasgow, Jaimee
    Publication type:
    Article
    4
    5

    Nintedanib plus Chemotherapy for Small Cell Lung Cancer with Comorbid Idiopathic Pulmonary Fibrosis.

    Published in:
    Annals of the American Thoracic Society, 2024, v. 21, n. 4, p. 635, doi. 10.1513/AnnalsATS.202311-941OC
    By:
    • Ikeda, Satoshi;
    • Ogura, Takashi;
    • Kato, Terufumi;
    • Kenmotsu, Hirotsugu;
    • Agemi, Yoko;
    • Tokito, Takaaki;
    • Ito, Kentaro;
    • Isomoto, Kohsuke;
    • Takiguchi, Yuichi;
    • Yoneshima, Yasuto;
    • Yokoyama, Toshihide;
    • Harada, Toshiyuki;
    • Tanzawa, Shigeru;
    • Kobayashi, Nobuaki;
    • Iwasawa, Tae;
    • Misumi, Toshihiro;
    • Okamoto, Hiroaki
    Publication type:
    Article
    6
    7
    8

    Tepotinib in patients with NSCLC harbouring MET exon 14 skipping: Japanese subset analysis from the Phase II VISION study.

    Published in:
    Japanese Journal of Clinical Oncology, 2021, v. 51, n. 8, p. 1261, doi. 10.1093/jjco/hyab072
    By:
    • Sakai, Hiroshi;
    • Morise, Masahiro;
    • Kato, Terufumi;
    • Matsumoto, Shingo;
    • Sakamoto, Tomohiro;
    • Kumagai, Toru;
    • Tokito, Takaaki;
    • Atagi, Shinji;
    • Kozuki, Toshiyuki;
    • Tanaka, Hiroshi;
    • Chikamori, Kenichi;
    • Shinagawa, Naofumi;
    • Takeoka, Hiroaki;
    • Bruns, Rolf;
    • Straub, Josef;
    • Schumacher, Karl Maria;
    • Paik, Paul K
    Publication type:
    Article
    9
    10
    11
    12
    13
    14
    15
    16

    Predicting osimertinib‐treatment outcomes through EGFR mutant‐fraction monitoring in the circulating tumor DNA of EGFR T790M‐positive patients with non‐small cell lung cancer (WJOG8815L).

    Published in:
    Molecular Oncology, 2021, v. 15, n. 1, p. 126, doi. 10.1002/1878-0261.12841
    By:
    • Sakai, Kazuko;
    • Takahama, Takayuki;
    • Shimokawa, Mototsugu;
    • Azuma, Koichi;
    • Takeda, Masayuki;
    • Kato, Terufumi;
    • Daga, Haruko;
    • Okamoto, Isamu;
    • Akamatsu, Hiroaki;
    • Teraoka, Shunsuke;
    • Ono, Akira;
    • Ohira, Tatsuo;
    • Yokoyama, Toshihide;
    • Yamamoto, Nobuyuki;
    • Nakagawa, Kazuhiko;
    • Nishio, Kazuto
    Publication type:
    Article
    17
    18
    19

    Erratum to: Pemetrexed and carboplatin followed by pemetrexed maintenance therapy in chemo-naïve patients with advanced nonsquamous non-small-cell lung cancer.

    Published in:
    2013
    By:
    • Okamoto, Isamu;
    • Aoe, Keisuke;
    • Kato, Terufumi;
    • Hosomi, Yukio;
    • Yokoyama, Akira;
    • Imamura, Fumio;
    • Kiura, Katsuyuki;
    • Hirashima, Tomonori;
    • Nishio, Makoto;
    • Nogami, Naoyuki;
    • Okamoto, Hiroaki;
    • Saka, Hideo;
    • Yamamoto, Nobuyuki;
    • Yoshizuka, Naoto;
    • Sekiguchi, Risa;
    • Kiyosawa, Kazuhiro;
    • Nakagawa, Kazuhiko;
    • Tamura, Tomohide
    Publication type:
    Journal Article
    20

    Pemetrexed and carboplatin followed by pemetrexed maintenance therapy in chemo-naïve patients with advanced nonsquamous non-small-cell lung cancer.

    Published in:
    Investigational New Drugs, 2013, v. 31, n. 5, p. 1275, doi. 10.1007/s10637-013-9941-z
    By:
    • Okamoto, Isamu;
    • Aoe, Keisuke;
    • Kato, Terufumi;
    • Hosomi, Yukio;
    • Yokoyama, Akira;
    • Imamura, Fumio;
    • Kiura, Katsuyuki;
    • Hirashima, Tomonori;
    • Nishio, Makoto;
    • Nogami, Naoyuki;
    • Okamoto, Hiroaki;
    • Saka, Hideo;
    • Yamamoto, Nobuyuki;
    • Yoshizuka, Naoto;
    • Sekiguchi, Risa;
    • Kiyosawa, Kazuhiro;
    • Nakagawa, Kazuhiko;
    • Tamura, Tomohide
    Publication type:
    Article
    21

    Erratum to: Pemetrexed and carboplatin followed by pemetrexed maintenance therapy in chemo-naïve patients with advanced nonsquamous non-small-cell lung cancer.

    Published in:
    2013
    By:
    • Okamoto, Isamu;
    • Aoe, Keisuke;
    • Kato, Terufumi;
    • Hosomi, Yukio;
    • Yokoyama, Akira;
    • Imamura, Fumio;
    • Kiura, Katsuyuki;
    • Hirashima, Tomonori;
    • Nishio, Makoto;
    • Nogami, Naoyuki;
    • Okamoto, Hiroaki;
    • Saka, Hideo;
    • Yamamoto, Nobuyuki;
    • Yoshizuka, Naoto;
    • Sekiguchi, Risa;
    • Kiyosawa, Kazuhiro;
    • Nakagawa, Kazuhiko;
    • Tamura, Tomohide
    Publication type:
    Correction Notice
    22

    Quality of Life with Gefitinib in Patients with EGFR-Mutated Non-Small Cell Lung Cancer: Quality of Life Analysis of North East Japan Study Group 002 Trial.

    Published in:
    2012
    By:
    • Oizumi, Satoshi;
    • Kobayashi, Kunihiko;
    • Inoue, Akira;
    • Maemondo, Makoto;
    • Sugawara, Shunichi;
    • Yoshizawa, Hirohisa;
    • Isobe, Hiroshi;
    • Harada, Masao;
    • Kinoshita, Ichiro;
    • Okinaga, Shoji;
    • Kato, Terufumi;
    • Harada, Toshiyuki;
    • Gemma, Akihiko;
    • Saijo, Yasuo;
    • Yokomizo, Yuki;
    • Morita, Satoshi;
    • Hagiwara, Koichi;
    • Nukiwa, Toshihiro
    Publication type:
    Journal Article
    23

    Quality of Life with Gefitinib in Patients with EGFR-Mutated Non-Small Cell Lung Cancer: Quality of Life Analysis of North East Japan Study Group 002 Trial.

    Published in:
    Oncologist, 2012, v. 17, n. 6, p. 863, doi. 10.1634/theoncologist.2011-0426
    By:
    • OIZUMI, SATOSHI;
    • KOBAYASHI, KUNIHIKO;
    • INOUE, AKIRA;
    • MAEMONDO, MAKOTO;
    • SUGAWARA, SHUNICHI;
    • YOSHIZAWA, HIROHISA;
    • ISOBE, HIROSHI;
    • HARADA, MASAO;
    • KINOSHITA, ICHIRO;
    • OKINAGA, SHOJI;
    • KATO, TERUFUMI;
    • HARADA, TOSHIYUKI;
    • GEMMA, AKIHIKO;
    • SAIJO, YASUO;
    • YOKOMIZO, YUKI;
    • MORITA, SATOSHI;
    • HAGIWARA, KOICHI;
    • NUKIWA, TOSHIHIRO
    Publication type:
    Article
    24

    Prognostic Significance of Plasma Neutrophil Extracellular Trap Levels in Patients with Non-Small Cell Lung Cancer Treated with Immune Checkpoint Inhibitors.

    Published in:
    Biomedicines, 2024, v. 12, n. 8, p. 1831, doi. 10.3390/biomedicines12081831
    By:
    • Horaguchi, Shun;
    • Nakahara, Yoshiro;
    • Igarashi, Yuka;
    • Kouro, Taku;
    • Wei, Feifei;
    • Murotani, Kenta;
    • Udagawa, Seiichi;
    • Higashijima, Naoko;
    • Matsuo, Norikazu;
    • Murakami, Shuji;
    • Kato, Terufumi;
    • Kondo, Tetsuro;
    • Xiang, Huihui;
    • Kasajima, Rika;
    • Himuro, Hidetomo;
    • Tsuji, Kayoko;
    • Mano, Yasunobu;
    • Komahashi, Mitsuru;
    • Miyagi, Yohei;
    • Saito, Haruhiro
    Publication type:
    Article
    25
    26
    27

    A phase II study of cisplatin plus vinorelbine combined with atezolizumab as adjuvant therapy for completely resected non-small-cell lung cancer with EGFR mutation (West Japan Oncology Group 11719L/ADJUST study).

    Published in:
    Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/1758835920987647
    By:
    • Shibaki, Ryota;
    • Akamatsu, Hiroaki;
    • Kato, Terufumi;
    • Nishino, Kazumi;
    • Okada, Morihito;
    • Mitsudomi, Tetsuya;
    • Wakuda, Kazushige;
    • Yoshimura, Kenichi;
    • Yamamoto, Nobuyuki;
    • Nakagawa, Kazuhiko
    Publication type:
    Article
    28
    29
    30
    31

    Phase I/II study of induction chemotherapy using carboplatin plus irinotecan and sequential thoracic radiotherapy (TRT) for elderly patients with limited-disease small-cell lung cancer (LD-SCLC): TORG 0604.

    Published in:
    2017
    By:
    • Yuki Misumi;
    • Hiroaki Okamoto;
    • Jiichiro Sasaki;
    • Noriyuki Masuda;
    • Mari Ishii;
    • Tsuneo Shimokawa;
    • Yukio Hosomi;
    • Yusuke Okuma;
    • Makoto Nagamata;
    • Takashi Ogura;
    • Terufumi Kato;
    • Masafumi Sata;
    • Sakiko Otani;
    • Akira Takakura;
    • Koichi Minato;
    • Yosuke Miura;
    • Takuma Yokoyama;
    • Saori Takata;
    • Katsuhiko Naoki;
    • Koshiro Watanabe
    Publication type:
    journal article
    32
    33

    Clinical and imaging features of interstitial lung disease in cancer patients treated with trastuzumab deruxtecan.

    Published in:
    International Journal of Clinical Oncology, 2023, v. 28, n. 12, p. 1585, doi. 10.1007/s10147-023-02414-x
    By:
    • Baba, Tomohisa;
    • Kusumoto, Masahiko;
    • Kato, Terufumi;
    • Kurihara, Yasuyuki;
    • Sasaki, Shinichi;
    • Oikado, Katsunori;
    • Saito, Yoshinobu;
    • Endo, Masahiro;
    • Fujiwara, Yutaka;
    • Kenmotsu, Hirotsugu;
    • Sata, Masafumi;
    • Takano, Toshimi;
    • Kato, Ken;
    • Hirata, Koji;
    • Katagiri, Tomomi;
    • Saito, Hanako;
    • Kuwano, Kazuyoshi
    Publication type:
    Article
    34
    35
    36
    37
    38
    39

    A phase II study of cisplatin plus vinorelbine combined with atezolizumab as adjuvant therapy for completely resected non-small-cell lung cancer with EGFR mutation (West Japan Oncology Group 11719L/ADJUST study).

    Published in:
    Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/1758835920987647
    By:
    • Shibaki, Ryota;
    • Akamatsu, Hiroaki;
    • Kato, Terufumi;
    • Nishino, Kazumi;
    • Okada, Morihito;
    • Mitsudomi, Tetsuya;
    • Wakuda, Kazushige;
    • Yoshimura, Kenichi;
    • Yamamoto, Nobuyuki;
    • Nakagawa, Kazuhiko
    Publication type:
    Article
    40
    41

    A Phase II Study to Assess the Efficacy of Osimertinib in Patients With EGFR Mutation-positive NSCLC Who Developed Isolated CNS Progression (T790M-negative or Unknown) During First- or Second-generation EGFR-TKI or Systemic Disease Progression (T790M-negative) After Treatment With First- or Second-generation EGFR-TKI and Platinum-based Chemotherapy (WJOG12819L)

    Published in:
    Clinical Lung Cancer, 2021, v. 22, n. 4, p. 376, doi. 10.1016/j.cllc.2020.12.009
    By:
    • Takeda, Masayuki;
    • Shimokawa, Mototsugu;
    • Nakamura, Atsushi;
    • Nosaki, Kaname;
    • Watanabe, Yasutaka;
    • Kato, Terufumi;
    • Hayakawa, Daisuke;
    • Tanaka, Hiroshi;
    • Takahashi, Toshiaki;
    • Kogure, Yoshihito;
    • Tachihara, Motoko;
    • Fujimoto, Daichi;
    • Yamaguchi, Kakuhiro;
    • Hamaguchi, Naohiko;
    • Okamoto, Isamu;
    • Azuma, Koichi;
    • Hasegawa, Kazuo;
    • Yamamoto, Nobuyuki;
    • Nakagawa, Kazuhiko
    Publication type:
    Article
    42
    43
    44

    Afatinib as First-line Treatment of Older Patients With EGFR Mutation-Positive Non-Small-Cell Lung Cancer: Subgroup Analyses of the LUX-Lung 3, LUX-Lung 6, and LUX-Lung 7 Trials.

    Published in:
    2018
    By:
    • Wu, Yi-Long;
    • Sequist, Lecia V;
    • Tan, Eng-Huat;
    • Geater, Sarayut L;
    • Orlov, Sergey;
    • Zhang, Li;
    • Lee, Ki Hyeong;
    • Tsai, Chun-Ming;
    • Kato, Terufumi;
    • Barrios, Carlos H;
    • Schuler, Martin;
    • Hirsh, Vera;
    • Yamamoto, Nobuyuki;
    • O'Byrne, Kenneth;
    • Boyer, Michael;
    • Mok, Tony;
    • Peil, Barbara;
    • Märten, Angela;
    • Chih-Hsin Yang, James;
    • Paz-Ares, Luis
    Publication type:
    journal article
    45

    Treatment Rationale and Design for J-SONIC: A Randomized Study of Carboplatin Plus Nab-paclitaxel With or Without Nintedanib for Advanced Non-Small-cell Lung Cancer With Idiopathic Pulmonary Fibrosis.

    Published in:
    2018
    By:
    • Kohei Otsubo;
    • Junji Kishimoto;
    • Hirotsugu Kenmotsu;
    • Yuji Minegishi;
    • Eiki Ichihara;
    • Akira Shiraki;
    • Terufumi Kato;
    • Shinji Atagi;
    • Hidehito Horinouchi;
    • Masahiko Ando;
    • Yasuhiro Kondoh;
    • Masahiko Kusumoto;
    • Kazuya Ichikado;
    • Nobuyuki Yamamoto;
    • Yoichi Nakanishi;
    • Isamu Okamoto;
    • Otsubo, Kohei;
    • Kishimoto, Junji;
    • Kenmotsu, Hirotsugu;
    • Minegishi, Yuji
    Publication type:
    journal article
    46
    47

    Treatment Rationale and Design for J-AXEL: A Randomized Phase 3 Study Comparing Nab-Paclitaxel With Docetaxel in Patients With Previously Treated Advanced Non—Small-Cell Lung Cancer.

    Published in:
    Clinical Lung Cancer, 2017, v. 18, n. 1, p. 100, doi. 10.1016/j.cllc.2016.08.003
    By:
    • Yasuto Yoneshima;
    • Satoshi Morita;
    • Masahiko Ando;
    • Satoru Miura;
    • Hiroshige Yoshioka;
    • Tetsuya Abe;
    • Terufumi Kato;
    • Masashi Kondo;
    • Yukio Hosomi;
    • Katsuyuki Hotta;
    • Nobuyuki Yamamoto;
    • Junji Kishimoto;
    • Yoichi Nakanishi;
    • Isamu Okamoto
    Publication type:
    Article
    48
    49

    Plasma screening for the T790M mutation of EGFR and phase 2 study of osimertinib efficacy in plasma T790M–positive non–small cell lung cancer: West Japan Oncology Group 8815L/LPS study.

    Published in:
    Cancer (0008543X), 2020, v. 126, n. 9, p. 1940, doi. 10.1002/cncr.32749
    By:
    • Takahama, Takayuki;
    • Azuma, Koichi;
    • Shimokawa, Mototsugu;
    • Takeda, Masayuki;
    • Ishii, Hidenobu;
    • Kato, Terufumi;
    • Saito, Haruhiro;
    • Daga, Haruko;
    • Tsuboguchi, Yuko;
    • Okamoto, Isamu;
    • Otsubo, Kohei;
    • Akamatsu, Hiroaki;
    • Teraoka, Shunsuke;
    • Takahashi, Toshiaki;
    • Ono, Akira;
    • Ohira, Tatsuo;
    • Yokoyama, Toshihide;
    • Sakai, Kazuko;
    • Yamamoto, Nobuyuki;
    • Nishio, Kazuto
    Publication type:
    Article
    50

    Epidermal growth factor receptor mutation analysis in tissue and plasma from the AURA3 trial: Osimertinib versus platinum-pemetrexed for T790M mutation-positive advanced non-small cell lung cancer.

    Published in:
    2020
    By:
    • Papadimitrakopoulou, Vassiliki A.;
    • Han, Ji‐Youn;
    • Ahn, Myung‐Ju;
    • Ramalingam, Suresh S.;
    • Delmonte, Angelo;
    • Hsia, Te‐Chun;
    • Laskin, Janessa;
    • Kim, Sang‐We;
    • He, Yong;
    • Tsai, Chun‐Ming;
    • Hida, Toyoaki;
    • Maemondo, Makoto;
    • Kato, Terufumi;
    • Jenkins, Suzanne;
    • Patel, Sabina;
    • Huang, Xiangning;
    • Laus, Gianluca;
    • Markovets, Aleksandra;
    • Thress, Kenneth S.;
    • Wu, Yi‐Long
    Publication type:
    journal article